Why are Indian generic drugs okay?

In the 1970s, India promulgated the patent law, which stipulated that the product patents of drugs were not protected, but only the patents of production processes and methods. At the same time, India has also promulgated drug price control regulations, thus restricting multinational pharmaceutical companies and indirectly protecting domestic generic drug companies.

After India's accession to the WTO, it must act according to international rules, and the previous one will not work.

So India revised the patent law and began to protect drug product patents, but India left itself a way out, that is, compulsory licensing and authorization restrictions on drug patents.

The so-called compulsory licensing means allowing developing countries to use the compulsory licensing system to produce patented drugs. To obtain a compulsory license, one of the following four conditions must be met.

(1) The copyright owner has not implemented or not fully implemented its patent.

(2) Compulsory license for the purpose of public interest.

(3) Compulsory license of anti-monopoly behavior.

④ Cross compulsory licensing of subordinate patents.